Atlas Trials

TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY

Clinical trial NCT04481256 · RECRUITING

Trial details

NCT number
NCT04481256
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Carcinoma, Squamous CellOesophageal Cancer
Start date
2020-11-11
Primary completion
2025-09-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.